About
Copy Link
Research
Copy Link
Research at a Glance
Yale Co-Authors
Frequent collaborators of Jingjing Jiao's published research.
Publications Timeline
A big-picture view of Jingjing Jiao's research output by year.
Xuchen Zhang, MD, PhD
Dhanpat Jain, MD
Raffaella Morotti, MD
Daniel Zelterman, PhD
Dieter Lindskog, MD
Hao Wu, MD, PhD
36Publications
301Citations
Publications
2025
Metastatic Breast Cancer to a Dedifferentiated Solitary Fibrous Tumor Arising from a PTEN Hamartoma of Soft Tissue
Jiao J, Lindskog D, Laskin W, Wu H. Metastatic Breast Cancer to a Dedifferentiated Solitary Fibrous Tumor Arising from a PTEN Hamartoma of Soft Tissue. International Journal Of Surgical Pathology 2025, 33: 1856-1861. PMID: 40452397, DOI: 10.1177/10668969251343903.Peer-Reviewed Case Reports and Technical NotesAltmetricConceptsDedifferentiated solitary fibrous tumorSolitary fibrous tumorPTEN hamartoma of soft tissueBreast cancerSoft tissueAssociated with other neoplasmsConventional solitary fibrous tumorMetastatic breast carcinomaGermline pathogenic variantsMetastatic breast cancerMetastatic ductal carcinomaPTEN hamartoma tumor syndromePlump spindle cellsDeep soft tissuesHamartoma tumor syndromePostzygotic mosaicismThin-walled vesselsPathogenic variantsPatternless patternFibrous tumorDuctal carcinomaBreast carcinomaGermline mutationsPediatric lesionsMyxoid backgroundHepatoblastoma: Comprehensive Review With Recent Updates
Jiao J, Saxena R, Morotti R. Hepatoblastoma: Comprehensive Review With Recent Updates. Advances In Anatomic Pathology 2025, 32: 309-316. PMID: 40178831, DOI: 10.1097/pap.0000000000000495.Peer-Reviewed Original ResearchCitationsConceptsRisk stratificationLiver tumorsChildren's Hepatic tumors International CollaborationPrimary malignant liver tumorsMalignant rhabdoid tumorMalignant liver tumorsPediatric liver tumorsRare pediatric liver tumorImprove risk stratificationRisk stratification algorithmChemotherapeutic regimenComplete resectionAdjuvant chemotherapyRhabdoid tumorPretreatment extentHistological heterogeneityHistological classificationHistological featuresHepatocellular neoplasmsDisease stageHepatoblastomaTumorImproved efficacyStratification algorithmReduced toxicitySteatotic Liver Disease: Navigating Pathologic Features, Diagnostic Challenges, and Emerging Insights.
Jiao J, Zhang X. Steatotic Liver Disease: Navigating Pathologic Features, Diagnostic Challenges, and Emerging Insights. Adv Anat Pathol 2025 PMID: 39895389, DOI: 10.1097/PAP.0000000000000483.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2024
Expanding the spectrum of progressive familial intrahepatic cholestasis: A report of 3 cases
Jiao J, Morotti R, Shafizadeh N, Jain D. Expanding the spectrum of progressive familial intrahepatic cholestasis: A report of 3 cases. American Journal Of Clinical Pathology 2024, 163: 332-339. PMID: 39333837, DOI: 10.1093/ajcp/aqae123.Peer-Reviewed Original ResearchConceptsProgressive familial intrahepatic cholestasisATP-binding cassette subfamily B member 4Whole-exome sequencingFamilial intrahepatic cholestasisIntrahepatic cholestasisDiagnostic challengeGroup of autosomal recessive disordersAbnormal liver function testsHomozygous splice site variantDrug-induced liver injuryHeterozygous frameshift mutationHeterozygous missense mutationLiver function testsAged 2 monthsAutosomal recessive disorderSplice site variantHistory of alcoholismABCB4 mutationsPediatric ageLiver biopsyClinical historyRecessive disorderLiver injuryMolecular testingHeterogeneous presentationPerioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer
Cecchini M, Salem R, Robert M, Czerniak S, Blaha O, Zelterman D, Rajaei M, Townsend J, Cai G, Chowdhury S, Yugawa D, Tseng R, Arbelaez C, Jiao J, Shroyer K, Thumar J, Kortmansky J, Zaheer W, Fischbach N, Persico J, Stein S, Khan S, Cha C, Billingsley K, Kunstman J, Johung K, Wiess C, Muzumdar M, Spickard E, Aushev V, Laliotis G, Jurdi A, Liu M, Escobar-Hoyos L, Lacy J. Perioperative Modified FOLFIRINOX for Resectable Pancreatic Cancer. JAMA Oncology 2024, 10: 1027-1035. PMID: 38900452, PMCID: PMC11190830, DOI: 10.1001/jamaoncol.2024.1575.Peer-Reviewed Original ResearchCitationsAltmetricConceptsProgression-free survivalPancreatic ductal adenocarcinomaOverall survivalCtDNA levelsPhase 2 nonrandomized controlled trialAnalysis of circulating tumor DNAMedian progression-free survivalResectable pancreatic ductal adenocarcinomaControlled TrialsAssess surgical candidacyBaseline ctDNA levelModified 5-fluorouracilResectable pancreatic cancerPancreatic protocol computed tomographyAssociated with recurrenceTumor molecular featuresAggressive malignant tumorKaplan-Meier estimatesRandomized clinical trialsStandard of careCtDNA-positivePreoperative cyclesNonrandomized controlled trialsUnresectable diseaseModified FOLFIRINOXArtificial intelligence–aided steatosis assessment in donor livers according to the Banff consensus recommendations
Jiao J, Tang H, Sun N, Zhang X. Artificial intelligence–aided steatosis assessment in donor livers according to the Banff consensus recommendations. American Journal Of Clinical Pathology 2024, 162: 401-407. PMID: 38716796, DOI: 10.1093/ajcp/aqae053.Peer-Reviewed Original ResearchCitationsAltmetricConceptsBanff Working GroupLiver Allograft PathologyBiopsy specimensDonor liversAllograft pathologyAssociated with primary graft dysfunctionMacrovesicular steatosisPrimary graft dysfunctionManual quantificationSteatosis assessmentLiver biopsy specimensSevere macrovesicular steatosisAssessment of liver steatosisGraft dysfunctionPathological evaluationModerate steatosisEvaluate steatosisConsensus recommendationsLiver steatosisSteatosisBanffLiverPathologyAI modelsArtificial intelligenceGlycerol Kinase Deficiency with Increased Triglycerides and Weight Gain: Pseudo or Real?
Jiao J, Bernard P, Meeusen J, Militello L, El-Khoury J. Glycerol Kinase Deficiency with Increased Triglycerides and Weight Gain: Pseudo or Real? Clinical Chemistry 2024, 70: 703-706. PMID: 38692658, DOI: 10.1093/clinchem/hvae032.Peer-Reviewed Original ResearchAltmetric
2023
Detection of Large-Droplet Macrovesicular Steatosis in Donor Livers Based on Segment-Anything Model
Tang H, Jiao J, Lin J, Zhang X, Sun N. Detection of Large-Droplet Macrovesicular Steatosis in Donor Livers Based on Segment-Anything Model. Laboratory Investigation 2023, 104: 100288. PMID: 37977550, DOI: 10.1016/j.labinv.2023.100288.Peer-Reviewed Original ResearchCitationsConceptsLiver diseaseMacrovesicular steatosisArtificial intelligence algorithmsArtificial intelligence modelsEnd-stage liver diseaseRule-based algorithmLiver histology analysisLiver transplant complicationsAcute liver failurePrimary hepatic malignancyLarge fat vacuolesIntelligence algorithmsDetection modelTransformer architectureIntelligence modelsTransplant complicationsLiver transplantationLiver failureLiver biopsyHepatic malignanciesFat vacuolesDonor organsEffective treatmentPrior knowledgeAlgorithmHeterogeneity in intrahepatic macrophage populations and druggable target expression in patients with steatotic liver disease-related fibrosis.
Saldarriaga OA, Wanninger TG, Arroyave E, Gosnell J, Krishnan S, Oneka M, Bao D, Millian DE, Kueht ML, Moghe A, Jiao J, Sanchez JI, Spratt H, Beretta L, Rao A, Burks JK, Stevenson HL. Heterogeneity in intrahepatic macrophage populations and druggable target expression in patients with steatotic liver disease-related fibrosis. JHEP Rep 2023, 6: 100958. PMID: 38162144, DOI: 10.1016/j.jhepr.2023.100958.Peer-Reviewed Original ResearchPostinfantile Giant Cell Hepatitis in Native and Allograft Livers: A Multi-Institutional Clinicopathologic Study of 70 Cases
Jiao J, Chezar K, Zhang X, Wang D, Cao W, Bindu C, Chen W, Neto A, Henn P, Riahi I, Wang H, Papke D, Zhao L, Xue Y, Liao X, Zhang X. Postinfantile Giant Cell Hepatitis in Native and Allograft Livers: A Multi-Institutional Clinicopathologic Study of 70 Cases. Modern Pathology 2023, 36: 100298. PMID: 37544363, DOI: 10.1016/j.modpat.2023.100298.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsPostinfantile giant cell hepatitisAutoimmune liver diseaseGiant cell hepatitisAlkaline phosphatase levelsClinical outcomesPhosphatase levelsLiver diseaseMulti-institutional retrospective studyAssociated with better survivalAssociated with poor survivalClinicopathological characteristics of patientsAdverse prognostic factorAssociated with autoimmune liver diseasesGiant cellsVariable clinical outcomesFollow-up resultsCharacteristics of patientsDistribution of giant cellsOlder ageLiver disease etiologyPrognostic factorsAdvanced fibrosisBetter survivalClinicopathological characteristicsLiver allografts
Academic Achievements & Community Involvement
Copy Link
Honors
honor Original Research - First Place
02/22/2025Regional AwardConnecticut Society of PathologistsDetailsUnited Stateshonor Pathologist-In-Training Travel Award
03/14/2023National AwardUSCAPDetailsUnited Stateshonor GoPath Best Abstract Award, 3rd place
03/14/2023Other AwardCAPA (Chinese American Pathologists Association)honor TREC Workshop Inaugural Cohort Fellowship
08/01/2017Regional AwardTransdisciplinary Research in Energetics and Cancer Research Education ProgramDetailsUnited Stateshonor CPRIT fellowship
08/04/2014Regional AwardUTHealth Innovation in Cancer Prevention Research Training ProgramDetailsUnited States
News
Copy Link
Get In Touch
Copy Link